StonvexLoading…
StonvexStonvexStonvexCore line items from RGTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.09M | $10.79M | $12.01M | $13.10M |
Operating Income | $-84.66M | $-68.51M | $-72.30M | $-109.08M |
Net Income | $-216.21M | $-200.99M | $-75.11M | $-71.52M |
EPS (Diluted) | $-0.70 | $-1.09 | $-0.57 | $-0.70 |
Total Assets | $666.57M | $284.79M | $159.91M | $203.44M |
Total Liabilities | $120.38M | $158.20M | $50.33M | $53.22M |
Cash & Equivalents | $44.85M | $67.67M | $21.39M | $57.89M |
Free Cash Flow OCF − CapEx | $-77.22M | $-61.73M | $-59.64M | $-85.43M |
Shares Outstanding | 331.28M | 283.55M | 147.07M | 125.26M |